Search results
Merck Gambled With Keytruda In 2011 — How That Jump Is Still Paying Off Today
Investor's Business Daily· 2 years agoA gamble Merck made more than 10 years ago could pay off again for the pharmaceutical giant's stock...
Advanced Esophageal Cancer and Immunotherapy
Verywell Health via Yahoo News· 10 months agoA Newer Treatment OptionMedically reviewed by Gagandeep Brar, MD Immunotherapy for esophageal cancer is a newer treatment approach shown to improve the...
Moderna Stock Breaks Out As Cancer Vaccine Shows Promise In Keytruda Tie-Up
Investor's Business Daily· 2 years agoModerna stock broke out Tuesday after the company said adding its personalized cancer vaccine to...
Jemperli contends with blockbuster Keytruda in endometrial cancer
Clinical Trials Arena via Yahoo Finance· 2 months agoOn April 24, the FDA granted Priority Review to the supplemental Biologics License Application...
How This New Merck Regimen Could 'Rewrite Textbooks' In Cancer Treatment — And Bolster 4 Stocks
Investor's Business Daily· 8 months agoMore than two-thirds of patients responded to an experimental bladder cancer treatment from Merck...
Personalized cancer vaccine results are a 'home run': Moderna CEO
Yahoo Finance via AOL· 2 years agoPreliminary results from a personalized cancer vaccine jointly studied by Moderna (MRNA) and Merck...
Merck stops testing combo drug for skin cancer as more patients discontinue
Reuters via Yahoo News· 1 month agoThis is the latest setback for the experimental drug, vibostolimab, and the related promising new...
New Skin Cancer Vaccine Cuts Risk of Relapse by 44%, Study Shows—Here’s What to Know
Prevention via Yahoo News· 1 year agoA new vaccine has shown promise in reducing the risk of developing skin cancer. Phase 2 clinical...
Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return
Reuters via Yahoo Finance· 1 year agoAn experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or...
Mirati Therapeutics Crashes As The Cancer Rivalry With Amgen Heats Up
Investor's Business Daily· 2 years agoMirati Therapeutics said almost half of patients responded to its lung cancer regimen, but MRTX...